Fabtech Technologies Cleanrooms Ltd
Incorporated in 2015, Fabtech Technologies Cleanrooms Limited is a global company specializing in turnkey engineering solutions for the pharmaceutical, biotech, and healthcare sectors.[1]
- Market Cap ₹ 579 Cr.
- Current Price ₹ 470
- High / Low ₹ 470 / 162
- Stock P/E 43.5
- Book Value ₹ 76.6
- Dividend Yield 0.43 %
- ROCE 21.1 %
- ROE 18.2 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 27.2% CAGR over last 5 years
Cons
- Promoter holding has decreased over last quarter: -24.7%
- The company has delivered a poor sales growth of 10.9% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Industrials Capital Goods Industrial Manufacturing Industrial Products
Part of BSE SME IPO
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 89 | 70 | 114 | 125 | 97 | 150 | |
| 83 | 69 | 107 | 112 | 89 | 134 | |
| Operating Profit | 6 | 1 | 6 | 13 | 9 | 16 |
| OPM % | 7% | 2% | 5% | 10% | 9% | 11% |
| 1 | 0 | 0 | 0 | 1 | 1 | |
| Interest | 1 | 0 | 1 | 1 | 1 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 0 | 1 |
| Profit before tax | 6 | 1 | 5 | 12 | 8 | 16 |
| Tax % | 28% | -42% | 29% | 31% | 25% | 24% |
| 4 | 1 | 4 | 8 | 6 | 13 | |
| EPS in Rs | 1,333.33 | 250.00 | 12.92 | 28.57 | 20.75 | 10.80 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 19% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | 10% |
| TTM: | 54% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 27% |
| 3 Years: | 55% |
| TTM: | 130% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 17% |
| Last Year: | 18% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.03 | 0.03 | 3 | 3 | 3 | 12 |
| Reserves | 31 | 32 | 35 | 43 | 49 | 82 |
| 10 | 7 | 8 | 6 | 6 | 1 | |
| 26 | 30 | 36 | 29 | 32 | 28 | |
| Total Liabilities | 67 | 69 | 82 | 81 | 89 | 124 |
| 4 | 5 | 4 | 4 | 5 | 4 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 1 | 27 |
| 63 | 64 | 77 | 76 | 83 | 93 | |
| Total Assets | 67 | 69 | 82 | 81 | 89 | 124 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| -9 | 4 | 3 | 8 | 3 | 3 | |
| 2 | -1 | -4 | -3 | -2 | -26 | |
| 7 | -3 | 1 | -4 | -1 | 24 | |
| Net Cash Flow | 1 | -0 | -0 | 1 | 0 | 1 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 181 | 221 | 165 | 144 | 193 | 129 |
| Inventory Days | 63 | 95 | 63 | 57 | 88 | 67 |
| Days Payable | 114 | 146 | 105 | 82 | 122 | 74 |
| Cash Conversion Cycle | 130 | 170 | 123 | 119 | 159 | 122 |
| Working Capital Days | 154 | 179 | 119 | 111 | 156 | 178 |
| ROCE % | 2% | 14% | 26% | 16% | 21% |
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
12 Jul - Compliance certificate confirming dematerialisation process for quarter ended June 30, 2025.
-
General Announcement
11 Jul - June orders ₹11.5cr; order book ₹85.08cr; Q1 revenue ₹43.20cr, up from ₹32.75cr last year.
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 5 Jul
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 5 Jul
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 26 Jun
Annual reports
No data available.
Concalls
-
Jun 2025TranscriptPPT
-
Mar 2025TranscriptNotesPPT
-
Feb 2025TranscriptNotesPPT
Business Overview[1]
Fabtech Technologies Cleanrooms specializes in manufacturing and providing end-to-end solutions for pre-engineered and pre-fabricated modular panels and doors for cleanrooms. These cleanrooms are used in pharmaceutical, healthcare, and biotech sectors and adhere to global regulatory standards like ISO and FDA. The company offers services including design, engineering, manufacturing, quality assurance, installation, and validation.